Call for Abstracts
You are invited to contribute a paper in any one of the themes outlined below. Abstracts must be submitted no later than Monday 15th June 2009.
Abstracts will be reviewed by the Abstract Grading Committee and may be accepted to any part of the meeting. The Scientific Program Committee reserves the right to assign accepted papers to any of the presentation formats. All presentation formats will form integral elements of the Scientific Program. An author may submit more than one abstract.
Follow the guidelines exactly as abstracts will not be retyped. Abstracts not complying with the guidelines may be withdrawn by the Scientific Program Committee.
Abstracts are invited on all aspects of Perfusion and related topics, research and clinical papers are welcome. The following focus topics may be of special interest:
- Embolic Events
- Glucose management
- Temperature management
- Neurobehavioral Outcomes
- Geriatric Perfusion
- Pediatric Perfusion
- Research Methods
- Clinical Trials
- Perfusion methodology and new techniques
Papers will be presented as either free short (10 min) or long papers (15 min), or included as a focus point in a workshop.
In addition topics for inclusion in symposium and workshops are sought from participants at all times.
ABSTRACT DEADLINE: Friday June 29th, 2009
Abstract format instructions:
See the example below and follow the format exactly.
- Title, authors and institutions must be included in the document you submit.
- Select arial font type size 10.
- Abstract word limit is 250. The word limit relates only to the text of the abstract and does not include title, authors and institutions.
- The complete abstract must be no more than 15cm wide and 12cm in length.
- Use single line spacing.
- TITLE should be in UPPER CASE, bold and at the top of the abstract.
- The name of the presenting author to be indicated by an underlining (Michael McDonald CCP (Aust), Robert A Baker CCP (Aust), Timothy Willcox CCP (Aust)). The authors’ names (Christian Middle initial Surname, highest degree) should be followed by the institution, city, country (Sentence case).
- Abbreviations may be used but must be spelt out in full at the first mention followed by the abbreviation in parentheses.
- Please proof read your abstract carefully.
Sample abstract
PERICARDIAL SUCTION BLOOD - WHAT ARE WE DOING ABOUT IT?
Tim Willcox Dip Perf, CCP., Gillian Chase Dip Perf, CCP, Jean-Luc Charlier BSc. ECP, Katherine Place BSc. Dip Perf, CCP Jude Clark Dip Perf, CCP, Nathan Ibbott BSc. Dip Perf, CCP, Tom Hick BSc. ACPS, Rach van Uden ECP, Jennie O’Shea CCP. Green Lane Perfusion, Auckland City Hospital, NZ.
Introduction
In August 2004 we introduced the Dideco 903 Avant hard-shell membrane oxygenator (Mirandola, Italy) into our practice that incorporates a cardiotomy reservoir integral to the venous reservoir that enables Pericardial Suction Blood (PSB) to be separated from the circulation and sequestered.
Methods
Following ethics committee approval, a prospective audit of the treatment of PSB was conducted on 58 adult patients undergoing elective CPB at Auckland City Hospital. A sheet was filled out for each procedure to include patient demographics, whether unprocessed PSB was reinfused and reason for reinfusion, use of the blood cell processor, and perioperative haematology, blood product transfusion and blood loss.
Results
Pericardial suction blood was reinfused unprocessed in 28% of patients (group R) and sequestered and not returned in 72% (group S). The reason for reinfusion of PSB unprocessed in Group R was "excessive volume" in all cases.
While the age and weight of patients both groups were similar (62.8 yrs v 65.5yrs and 81.5 Kg v 76.8Kg ) the case mix and CPB times were different. The O.R. discard suction was variably used regardless of whether PSB was sequestered or reinfused.
Discarded O.R. suction and sequestered PSB volumes.
|
Group R |
Group S |
p |
|
Mean OR discard suction (ml) |
545 |
439 |
ns |
|
Mean OR discard equated units |
0.86 |
0.35 |
0.02 |
|
Mean Sequestered PSB discarded |
249 |
125 |
ns |
|
Mean Sequestered PSB equated units discarded |
1.7 |
0.4 |
ns |
Where blood was not processed (n=45), in 53% no processor disposables were used. A cell processor reservoir plus aspiration line was used and wasted in 13% of cases, the majority of these being CABG.
Blood product use.
|
|
RBCs |
Plts |
FFP |
Cyro |
Donor Exp |
|
Group S |
1.4 |
0.36 |
0.5 |
0.05 |
3.8 |
|
Group R |
2.5 |
1.4 |
1.9 |
0.18 |
11.8 |
|
p |
ns |
ns |
ns |
ns |
0.02 |
There was no difference post operative chest drainage (24 hour) between Group R and Group S (770ml and 716ml respectively).
Conclusion
These limited data show the Avant 903 cardiotomy to enabled improved avoidance of reinfusion of cardiotomy blood with an open system (72% versus 4% for the year prior to its introduction. While there is level 1 evidence that PSB contains deleterious elements there is currently no strong evidence on the impact of avoidance of reinfusion of PSB on patient outcome. Further prospective clinical trials are warranted. CLOPIDOGREL AND BLEEDING AFTER CORONARY ARTERY BYPASS GRAFT SURGERY
|
Abstract Submissions
Electronic abstracts submission is preferred.
Email completed abstract (word document) to abstracts@perfusiondownunder.com Include in your email the presenter’s name, address, and telephone number.
Abstract may be mailed to:
Dr Rob Baker
Perfusion Downunder - The Winter Meeting
C/o:Cardiac Surgery Research Unit
Flinders Medical Centre
Bedford Park, Adelaide
South Australia 5042
If abstract is mailed please include a copy on cd of the abstract in word document format. Include the presenter’s name, address, email address and telephone number.
Speaker Timeline
Deadline for receipt of abstracts: 15th June 2009
Notification of acceptance: 9th July 2009
Speaker Expenses:
All presenters are required to pay their own registration, accommodation and travel expenses.
|
